High in-hospital mortality of intensive care patients with nucleated red blood cells in blood

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 8, 2004, Pages 933-938

  Stachon, Axel ^a   Holland Letz, Tim ^b   Krieg, Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Intensive care; Mortality; Nucleated red blood cells

Indexed keywords

ACCIDENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD CELL; BLOOD LEVEL; BLOOD SAMPLING; CELL NUCLEUS; CONTROLLED STUDY; CRITICAL ILLNESS; DEATH; ERYTHROCYTE; FEMALE; FREQUENCY ANALYSIS; GENERAL SURGERY; HEMATOLOGICAL PARAMETERS; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERNAL MEDICINE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THORAX SURGERY; TIME; UNIVERSITY HOSPITAL;

ERYTHROBLASTS; ERYTHROCYTE COUNT; FEMALE; GERMANY; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 4444316077     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.151     Document Type: Article

References (17)

1. Schwartz SO. Significance of nucleated red blood cells in peripheral blood. J Am Med Assoc 1954;154:1339-40.
2. Delsol G, Guiu-Godfrin B, Guiu M, Pris J, Corberand J, Fabre J. Leukoerythroblastosis and cancer frequency, prognosis, and physiopathologic significance. Cancer 1979;44:1009-13.
3. Budmiger H, Graf C, Streuli RA. The leukoerythroblastic blood picture. Incidence and clinical significance. Schweiz Rundsch Med Prax 1984;73:1489-93.
4. Weick JK, Hagedorn AB, Linman JW. Leukoerythroblastosis. Mayo Clin Proc 1974;49:110-3.
5. West CD, Ley AB, Pearson OH. Myelophthisic anemia in cancer of the breast. Am J Med 1955;18:923-31.
6. Mettier SR. Hematologic aspects of space consuming lesions of the bone marrow (myelophtisic anemia). Ann Intern Med 1940;14:436-48.
7. Andres WA. Normoblastemia after thermal injury. Am J Surg 1976;131:725-6.
8. Tavassoli M. Erythroblastemia. West J Med 1975; 122:194-8.
9. Stachon A, Böning A, Krismann M, Weisser H, Laczkovics A, Skipka G, et al. Prognostic significance of erythroblasts in blood after cardiothoracic surgery. Clin Chem Lab Med 2001;39:239-43.
10. Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med 2001; 125:391-6.
11. Walters J, Garrity P. Performance evaluation of the Sysmex XE-2100 hematology analyser. Lab Hematol 2000;6:83-92.
12. Briggs C, Harrison P, Grant D, Staves J, Maciag T. New quantitative parameters on recently introduced automated blood cell counter - the XE 2100™. Clin Lab Haematol 2000;22:345-50.
13. Stachon A, Sondermann N, Krieg M. Incidence of nucleated red blood cells in the blood of hospitalised patients. Infusion Ther Transfus Med 2001;28:263-6.
14. Stachon A, Sondermann N, Imöhl M, Krieg M. Nucleated red blood cells indicate high risk for in-hospital mortality. J Lab Clin Med 2002;140:407-12.
15. Böning A, Stachon A, Weisser H, Krismann M, Skipka G, Laczkovics A, et al. Postoperative cholesterol and erythroblasts as a parameter of perioperative mortality after cardiothoracic surgery. Z Herz Thorax Gefäßchir 2001;15:242-8.
16. Stachon A, Eisenblätter K, Köller M, Holland-Letz T, Krieg M. Cytokines and erythropoietin in the blood of patients with erythroblastemia. Acta Haematol 2003;110:204-6.
17. Livingston DH, Anjarina D, Wu J, Hauser CJ, Chang V, Deitch EA, et al. Bone marrow failure following severe injury in humans. Ann Surg 2003;238:748-53.